Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis

• Benign metastasizing leiomyomatosis (BML) is a rare condition. • Treatment options have traditionally included surgical resection or hormonal based therapy. • Traditional chemotherapy for BML is ineffective. • Our patient has had a prolonged response of stable disease with the anti-VEGF therapy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chhabra, Shalini, Sangani, Pooja, Saig, Reagan, Stany, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068955/
https://www.ncbi.nlm.nih.gov/pubmed/35531358
http://dx.doi.org/10.1016/j.gore.2021.100903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068955/
https://www.ncbi.nlm.nih.gov/pubmed/35531358
http://dx.doi.org/10.1016/j.gore.2021.100903

Ejemplares similares